» Related Searches: drug, cancer risk, breast cancer, cancer patients, prostate cancer
Results 51 to 60 of 68 
Biotech company Arqule said interim results of an early-stage antitumor drug trial
showed positive results, lifting the company's stock … 



Reata Pharmaceuticals has reported interim results from its ongoing phase I trial of RTA
744 in advanced primary brain tumors that showed evidence of strong drug activity … 



Studies of a rare genetic condition that increases cancer risk have unveiled a
potential treatment for metabolic syndrome, a common disorder that afflicts as many as one
in every four … 



F Brunstein, J Rens, S T van Tiel, A M M Eggermont & T L M ten Hagen … 



The seizure drug Lyrica may offer extended pain relief for people with fibromyalgia,
new research finds. Patients given higher does of a drug to treat anemia and
cancer have an … 
… cancer. The deal was worth $59M, along with two additional payments of $12....
(more) … 
Pharmion Corporation has purchased private oncology company Cabrellis, which holds the US
and EU rights to lung cancer drug amrubicin, for $59 million … 
A new medical study suggests that high doses of a best- selling drug used to treat
anemia in dialysis and cancer patients may increase the risk of heart problems and … 
Filed under: Drug, Prevention, Cervical Cancer, Clinical Trials, Research Back
in the summer of 2000, a year before I was diagnosed with breast cancer, I was told I
had an … 



Cancer drug company Adherex Technologies Inc. said Monday that its third quarter loss
widened in 2006 because of higher operating expenses tied to ongoing clinical trials … 


